Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004059596 | SCV002720272 | uncertain significance | not specified | 2021-06-22 | criteria provided, single submitter | clinical testing | The p.P68L variant (also known as c.203C>T), located in coding exon 1 of the GALNT12 gene, results from a C to T substitution at nucleotide position 203. The proline at codon 68 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |